JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB169901

Recombinant human c-Myc protein (Active)

5

(3 Reviews)

|

(14 Publications)

Recombinant human c-Myc protein (Active) is a Human Full Length protein, in the 1 to 454 aa range, expressed in Escherichia coli, with >93% purity, 5 EU/µg endotoxin level and suitable for western blot, SDS-PAGE, Functional studies and mass spectrometry. The predicted molecular weight of ab169901 protein is 53 kDa.

- Save time and ensure accurate results - use our recombinant c-Myc protein as a control
- Optimal protein bioactivity, stability and reproducibility
- Cited in over 10 publications

View Alternative Names

BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39

Key facts

Purity

>93% SDS-PAGE

Endotoxin level

5 EU/µg

Expression system

Escherichia coli

Tags

Tag free

Applications

SDS-PAGE, Mass Spec, FuncS, WB

applications

Biologically active

Yes

Biological activity

Reprogramming mouse fibroblast cell to iPS cells using 3 retroviral vectors, which carry Oct4, Sox2 & Klf4 with this protein as replacement assay. 8 μg/ml of human Klf4-11R were added in reprogramming medium every 48 hours for 20 days.

Intracellular protein penetration rate was tested using DyLight labeled ab169901 protein at 1 μg/ ml for 30 min incubation for human fibroblast cells at 37oC. More than 90% cell will be positive one hour after sample incubation.

Accession

P01106

Animal free

No

Carrier free

Yes

Species

Human

Storage buffer

pH: 7.5 Constituents: 0.24% Tris

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "Mass Spec": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

You may be interested in:

AB277452

Human c-Myc ELISA Kit

0

0 Reviews

View product

We recommend this product because it’s often used in the same experiment or related research.

We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.

Product details

Ensure the validity of your result using our bioactive recombinant human c-Myc protein ab169901 as a positive control in western blot and SDS-PAGE.

ab169901 is fused to an eleven arginine (11R) membrane penetration domain at the C terminus to enable penetration across the plasma membrane of mammalian cells.

Cellular Toxicity: The ab169901 recombinant protein was tested on mouse embryonic stem cells up to 50 µg/mL in culture medium. Suggested reprogramming protein concentration is between 0.5 to 8 µg/mL for both human and mouse fibroblast cells applications.


Check out our protein gel staining guide for SDS-PAGE here

Check out of western blot protocol for more information here

Sequence info

[{"sequence":"MDFFRVVENQQPPATMPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTELLGGDMVNQSFICDPDDETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPARGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLSSTESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAGGHSKPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSPRSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCAESGGGGSPGRRRRRRRRRRR","proteinLength":"Full Length","predictedMolecularWeight":"53 kDa","actualMolecularWeight":null,"aminoAcidEnd":454,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P01106","tags":[]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
True

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C-Myc also known simply as Myc or MYC protein is a transcription factor with significant roles in cellular processes. Its estimated molecular weight is approximately 62 kDa. This protein is expressed in various tissues and cell types including common use in HEK (human embryonic kidney) cells for research. c-Myc functions by regulating transcription of genes involved in cell cycle progression apoptosis and cellular transformation.
Biological function summary

C-Myc is involved in regulating cell growth and proliferation. It forms part of the Myc/Max complex which binds to DNA to regulate gene expression. This activity affects cellular metabolism ribosome biogenesis and cell cycle entry emphasizing its regulation of cellular energy and stress response. Its expression levels critically govern normal cellular functions and homeostasis.

Pathways

C-Myc plays an important role in the cell cycle pathway and apoptosis regulation. Specifically c-Myc is associated with the Wnt signaling pathway which influences cellular proliferation and differentiation. It also interacts with other proteins like Cyclin D1 influencing cell cycle control. These interactions ensure c-Myc's involvement in regulating key processes related to cell proliferation and stability.

C-Myc is tightly linked to cancer such as Burkitt's lymphoma and colon cancer. In these conditions c-Myc overexpression contributes to uncontrolled cell proliferation. Additionally c-Myc is associated with other oncogenic proteins like BCL2 in tumorigenesis highlighting its pivotal role in cancer development and progression. Understanding c-Myc's involvement in these diseases aids in the development of targeted therapeutic strategies.

Specifications

Form

Liquid

Additional notes

ab169901 was expressed in E. coli as inclusion bodies, solubilized, refolded, and further purified.

General info

Function

Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed : 24940000, PubMed : 25956029). Activates the transcription of growth-related genes (PubMed : 24940000, PubMed : 25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed : 24940000, PubMed : 25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed : 20010808).

Post-translational modifications

Phosphorylated by PRKDC (PubMed:1597196). Phosphorylation at Ser-344 by PIM2 leads to the stabilization of MYC (By similarity). Phosphorylation at Ser-77 by CDK2 prevents Ras-induced senescence (PubMed:19966300, PubMed:20713526). Phosphorylated at Ser-77 by DYRK2; this primes the protein for subsequent phosphorylation by GSK3B at Thr-73 (PubMed:22307329). Phosphorylation at Thr-73 and Ser-77 by GSK3 is required for ubiquitination and degradation by the proteasome (PubMed:15103331, PubMed:17558397, PubMed:8386367). Dephosphorylation at Ser-77 by protein phosphatase 2A (PPP2CA) promotes its degradation; interaction with PPP2CA is enhanced by AMBRA1 (PubMed:25438055, PubMed:25803737).. Ubiquitinated by the SCF(FBXW7) complex when phosphorylated at Thr-73 and Ser-77, leading to its degradation by the proteasome (PubMed:15103331, PubMed:17558397, PubMed:25775507). In the nucleoplasm, ubiquitination is counteracted by USP28, which interacts with isoform 1 of FBXW7 (FBW7alpha), leading to its deubiquitination and preventing degradation (PubMed:17558397, PubMed:17873522). In the nucleolus, however, ubiquitination is not counteracted by USP28 but by USP36, due to the lack of interaction between isoform 3 of FBXW7 (FBW7gamma) and USP28, explaining the selective MYC degradation in the nucleolus (PubMed:17558397, PubMed:25775507). Also polyubiquitinated by the DCX(TRPC4AP) complex (PubMed:20551172, PubMed:29779948). Ubiquitinated by UBR5 when not forming a heterodimer with another bHLH protein, leading to its degradation: UBR5 recognizes and binds a degron that is only available upon heterodimer dissociation (PubMed:33208877, PubMed:37478862). Ubiquitinated by TRIM6 in a phosphorylation-independent manner (By similarity).

Subcellular localisation

Nucleus

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed : 24940000, PubMed : 25956029). Activates the transcription of growth-related genes (PubMed : 24940000, PubMed : 25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed : 24940000, PubMed : 25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed : 20010808).
See full target information MYC

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Signal transduction and targeted therapy 10:206 PubMed40588481

2025

Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis.

Applications

Unspecified application

Species

Unspecified reactive species

Martina Lepore Signorile,Elisabetta Di Nicola,Giovanna Forte,Paola Sanese,Candida Fasano,Vittoria Disciglio,Katia De Marco,Marialaura Latrofa,Loris De Cecco,Marica Ficorilli,Marta Lucchetta,Erica Torchia,Chiara Dossena,Giusy Bianco,Vito Spilotro,Claudia Ferroni,Nicoletta Labarile,Raffaele Armentano,Francesco Albano,Anna Mestice,Gianluigi Gigante,Valerio Lantone,Giuliano Lantone,Leonardo Vincenti,Alberto Del Rio,Greta Varchi,Valentina Grossi,Cristiano Simone

Cellular and molecular life sciences : CMLS 82:3 PubMed39680126

2024

Phosphocholine inhibits proliferation and reduces stemness of endometrial cancer cells by downregulating mTOR-c-Myc signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Kunxiang Gong,Yanqin Zheng,Yaqiong Liu,Tiansong Zhang,Yiming Song,Weiwei Chen,Lirong Guo,Jie Zhou,Wenjie Liu,Tianlin Fang,Yun Chen,Jingyao Wang,Feifei Pan,Kun Shi

Cancers 15: PubMed37627164

2023

In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Joelle C Boulos,Manik Chatterjee,Letian Shan,Thomas Efferth

Pharmaceutics 15: PubMed37111592

2023

The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Mohamed Elbadawi,Joelle C Boulos,Mona Dawood,Min Zhou,Waseem Gul,Mahmoud A ElSohly,Sabine M Klauck,Thomas Efferth

Cancers 14: PubMed36230763

2022

c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Martina Lepore Signorile,Valentina Grossi,Candida Fasano,Giovanna Forte,Vittoria Disciglio,Paola Sanese,Katia De Marco,Francesca La Rocca,Raffaele Armentano,Anna Maria Valentini,Gianluigi Giannelli,Cristiano Simone

Cells 11: PubMed35406744

2022

The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Nisha Rani Dahiya,Boris A Leibovitch,Rama Kadamb,Nidhi Bansal,Samuel Waxman

Frontiers in genetics 12:741867 PubMed35069677

2022

Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the Promoter.

Applications

Unspecified application

Species

Unspecified reactive species

Carla J Cohen,Connor Davidson,Carlo Selmi,Paul Bowness,Julian C Knight,B Paul Wordsworth,Matteo Vecellio

Cell stem cell 29:298-314.e9 PubMed35045331

2022

TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity.

Applications

Unspecified application

Species

Unspecified reactive species

Tomoya Muto,Maria Guillamot,Jennifer Yeung,Jing Fang,Joshua Bennett,Bettina Nadorp,Audrey Lasry,Luna Zea Redondo,Kwangmin Choi,Yixiao Gong,Callum S Walker,Kathleen Hueneman,Lyndsey C Bolanos,Laura Barreyro,Lynn H Lee,Kenneth D Greis,Nikita Vasyliev,Alireza Khodadadi-Jamayran,Evgeny Nudler,Amaia Lujambio,Scott W Lowe,Iannis Aifantis,Daniel T Starczynowski

Cell chemical biology 28:4-13.e17 PubMed32966806

2020

Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYC.

Applications

Unspecified application

Species

Unspecified reactive species

Lydia Boike,Alexander G Cioffi,Felix C Majewski,Jennifer Co,Nathaniel J Henning,Michael D Jones,Gang Liu,Jeffrey M McKenna,John A Tallarico,Markus Schirle,Daniel K Nomura

Cancer cell 36:483-497.e15 PubMed31679823

2019

Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Huiying Han,Atul D Jain,Mihai I Truica,Javier Izquierdo-Ferrer,Jonathan F Anker,Barbara Lysy,Vinay Sagar,Yi Luan,Zachary R Chalmers,Kenji Unno,Hanlin Mok,Rajita Vatapalli,Young A Yoo,Yara Rodriguez,Irawati Kandela,J Brandon Parker,Debabrata Chakravarti,Rama K Mishra,Gary E Schiltz,Sarki A Abdulkadir
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Product
Proteins & Peptides

AB135024

Recombinant human c-Myc (mutated T73A) protein

proteins-peptides

recombinant-human-c-myc-mutated-t73a-protein-ab135024

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB84132

Recombinant Human c-Myc protein

proteins-peptides

recombinant-human-c-myc-protein-ab84132

4

(1 reviews)

Alternative Product
Proteins & Peptides

AB166837

Human c-Myc peptide

proteins-peptides

human-c-myc-peptide-ab166837

0

(0 reviews)

Alternative Product
Proteins & Peptides

AB235798

Recombinant Human c-Myc protein (Tagged)

proteins-peptides

recombinant-human-c-myc-protein-tagged-ab235798

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com